on Business Insurance Uncategorized

Read This Before You Sign: Common Endorsement Wording Traps in Directors and Officers (D&O) Liability Insurance

Directors and Officers (D&O) liability insurance is a critical safeguard for corporate leaders in the United States, but endorsement wording can quietly narrow protections or create gaps at claim time. This guide—focused on U.S. markets (notably New York and San Francisco)—walks through the most common endorsement traps, how they show up in policy language, likely financial impact, and practical negotiation fixes.

Why endorsements matter (short version)

Standard D&O forms are often amended by insurer endorsements, riders, and policy extensions that change coverage scope, exclusions, limits, and allocation/settlement mechanics. A single poorly worded endorsement can turn a $5,000 annual premium into an uncovered multimillion-dollar litigation exposure.

For market context: small private-company D&O policies (common limits: $1M aggregate) can start in low four figures, while mid-market private companies typically pay $10k–$50k for similar limits; public companies often face premiums in the tens to hundreds of thousands for comparable limits depending on revenue and volatility. Market reference: Insureon and Hiscox provide small-business D&O examples, while Chubb and major brokers report higher mid-market/public pricing and market trends. (Sources: Insureon, Hiscox, Chubb)

Top wording traps and how they operate

1. Narrow definition of "Loss" or "Damages"

  • Trap: Endorsements redefine “Loss” to exclude fines, civil penalties, or certain types of settlement payments (e.g., disgorgement).
  • Impact: Regulators’ penalties or SEC disgorgement orders may be excluded—potentially hundreds of thousands to millions in exposure for public companies.
  • Fix: Insist on language restoring coverage for “defense costs and settlements” except for uninsurable fines where prohibited by law; add a carveback specifically for SEC investigatory defense costs.

2. Restrictive “Insured vs. Insured” or Named Plaintiff exclusions

  • Trap: Broad insured vs. insured exclusions eliminate coverage for derivative suits, shareholder class actions, or employment-related suits brought by an insured entity or employee.
  • Impact: Derivative litigation defense costs can quickly exceed $1M.
  • Fix: Limit the exclusion to fraud or deliberate dishonest acts; add carvebacks for shareholder derivative suits and employment-related claims.

3. Retroactive date / prior acts narrowings

  • Trap: Endorsements establish or move a retroactive/prior acts date or tighten what constitutes a prior-act “claim.”
  • Impact: Claims arising from earlier conduct get excluded—even if the insured had continuous D&O coverage historically.
  • Fix: Secure continuous coverage language, or push the retroactive date back to company formation or the date of first D&O coverage.

4. Allocation and settlement clauses favoring the insurer

  • Trap: Wording permits insurer to force allocation of settlement dollars away from insured individuals toward the entity (or vice versa), or to settle without consent when “reasonable.”
  • Impact: Directors may lose Side A protection when entity funds are exhausted; settlement-driven exhaustion can leave individuals unprotected.
  • Fix: Require explicit Side A non-rescindable language, consent rights for settlement that affects Side A amounts, and fair allocation provisions (e.g., independent counsel or arbitration for allocation disputes). See detailed discussion in How a Side A Enhancement Endorsement Changes Directors and Officers (D&O) Liability Insurance Protection.

5. Broad regulatory/SEC exclusions

6. Contractual liability carveouts and indemnity traps

7. Insolvency / bankruptcy exclusions

  • Trap: Endorsements purport to exclude claims when the insured entity is insolvent or subject to bankruptcy solely when related to creditor claims.
  • Impact: Creditors’ suits in bankruptcy can arise immediately after insolvency, making this exclusion critical.
  • Fix: Narrow the exclusion to claims for which coverage is prohibited by bankruptcy law; negotiate carvebacks for fiduciary breaches alleged by creditors.

Quick comparison table: Common endorsement types, trap risk, negotiating leverage

Endorsement Type Typical Trap Wording Trap Risk (Low–High) Negotiation Tip
Side A Enhancement Limits on what Side A pays or insurer consent to settlement High Seek irrevocable Side A enhancement; limit insurer settlement rights
Prior Acts / Retro Date Sets/changes retroactive date High Restore prior date or add “continuous coverage” clause
Regulatory Investigation Rider Excludes investigatory costs High Add standalone investigatory defense coverage
Insured vs. Insured Exclusion Broadly bars employee/shareholder suits Medium–High Carveback for derivative/shareholder suits; exclude only fraud
Allocation & Settlement Grants insurer wide allocation/settlement powers High Require insured consent; independent allocation mechanism
Contractual Liability Excludes liabilities assumed by contract Medium Carve-in reasonable indemnities, M&A exceptions

Real-world pricing examples (U.S., illustrative ranges)

Pricing varies widely by revenue, industry, entity type (public vs. private), and jurisdiction. Below are approximate U.S.-market ranges (2024) to help you gauge cost vs. endorsement value:

  • Small private company (revenue <$5M), $1M limit: approximately $1,000–$6,000/year (Insureon, Hiscox examples).
  • Mid-market private company (revenue $50M–$500M), $5M–$10M limit: approximately $25,000–$150,000/year (market brokers; Chubb product pages indicate higher mid-market pricing).
  • Public companies: premiums commonly start in the mid-five-figures and can exceed $500,000+ for large, volatile companies or sectors under regulatory scrutiny (sources: brokers and underwriting market commentary).

Sources: Insureon small business samples, Hiscox small business D&O guidance, Chubb D&O market notes.

Negotiation checklist (practical steps before you sign)

  • Demand full policy text with all endorsements attached and read every defined term, especially “Loss,” “Claim,” “Insured,” and “Wrongful Act.”
  • Insist on express Side A non-rescindability and consent rights over settlements that deplete Side A.
  • Seek carvebacks for investigatory defense costs (SEC, DOJ) and for shareholder derivative suits.
  • Push for continuous coverage/retroactive language if your entity has prior coverage history.
  • Get allocation disputes covered by independent counsel or an arbitration mechanism.
  • For M&A or vendor-heavy businesses, add contractual liability carve-ins and specific M&A endorsements. See negotiation tactics in Negotiation Tips: Getting Favorable Wording for High‑Value Endorsements in Directors and Officers (D&O) Liability Insurance.

Final notes for New York & San Francisco boards

Directors in New York and San Francisco face heightened securities, employment, and regulatory activity. Excessively narrow endorsements in these jurisdictions can produce outsized exposure because legal and investigative costs are high—anticipate defense costs that can exceed $1M quickly for investigations. When negotiating endorsements, emphasize proven market language used by national carriers (Chubb, Starr, AIG) and consult your broker for precedent endorsements used in similar companies in your city.

Further reading from this endorsements cluster:

References

Recommended Articles